SCHEMBL9130742

SCHEMBL9130742

CC(C)(Oc1ccc(NC(=O)c2cc(Cl)cc(Cl)c2)cc1)C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARA Q07869 8/20 0.59
CYP1A2 P05177 2/20 0.59
CYP3A4 P08684 2/20 0.59
CYP2D6 P10635 2/20 0.59
CYP2C19 P33261 2/20 0.59
MEN1 O00255 1/20 0.59
MAPT P10636 1/20 0.59
KMT2A Q03164 1/20 0.59
PPARG P37231 3/20 0.56
FABP2 P12104 2/20 0.56
SLC22A12 Q96S37 1/20 0.56
SMN1; SMN2 Q16637 3/20 0.50
ALDH1A1 P00352 1/20 0.50
PPARD Q03181 1/20 0.50
TAS1R3 Q7RTX0 1/20 0.49
TAS1R1 Q7RTX1 1/20 0.49
TAS1R2 Q8TE23 1/20 0.49
TRPV1 Q8NER1 2/20 0.48
CYP2C9 P11712 1/20 0.47
NPC1 O15118 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16265333 0.90 PPARA (0.54) PPARACYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL12166209 0.88 PPARA (0.69) PPARACYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL16743455 0.85 PPARA (0.50) PPARACYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL1306107 0.85 PPARA (0.60) PPARACYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL16265332 0.82 PGR (0.60) PPARACYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL804816 0.82 TRPV1 (0.46) PPARACYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL16265334 0.82 TRPV1 (0.49) PPARACYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL16743452 0.81 RAB9A (0.71) CYP1A2CYP3A4CYP2D6CYP2C19MEN1
SCHEMBL16743652 0.81 NPC1 (0.64) PPARACYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL1304938 0.81 PPARA (0.74) PPARACYP1A2CYP3A4CYP2D6CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5472981-A Treating hemoglobin or blood in vivo or in vitro to modify the affinity of hemoglobin for oxygen MONTEFIORE MEDICAL CENTER (US) 1995-12-05 US disclosed
US-5292935-A Carboxyalkoxy-substituted diphenylurea MONTEFIORE MEDICAL CENTER (US) 1994-03-08 US disclosed
US-5093367-A Arylureidophenoxymethylpropionic acids which have activity in dissociation of oxygen from hemoglobin MONTEFIORE MEDICAL CENTER (US) 1992-03-03 US disclosed
EP-0420930-A4 METHOD OF SYNTHESIS AND NOVEL COMPOUNDS FOR PHARMACEUTICAL USES 1991-12-04 EP disclosed
EP-0420930-A1 METHOD OF SYNTHESIS AND NOVEL COMPOUNDS FOR PHARMACEUTICAL USES LALEZARI, Iraj (US) 1991-04-10 EP disclosed
US-4921997-A Method of synthesis and novel compounds for pharmaceutical uses MONTEFIORE MEDICAL CENTER (US) 1990-05-01 US disclosed
WO-1989012622-A1 METHOD OF SYNTHESIS AND NOVEL COMPOUNDS FOR PHARMACEUTICAL USES LALEZARI IRAJ (US) 1989-12-28 WO disclosed